Influence of venous drainage and hemofiltration on hypercirculatory instability after high volume crystalloid cardioplegia during coronary artery bypass surgery

Journal of Cardiovascular Surgery

Volumn 46, Issue 6, 2005, Pages 539-549

  Sirbu, H ^a   Busch, T ^a   Buhre, W ^b   Hilgers, R D ^a   Autschbach, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Catheterization; Coronary artery bypass; Extracorporeal circulation; Hemodynamics

Indexed keywords

CARDIOPLEGIC AGENT; HETASTARCH; HTK SOLUTION; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CAVA VEIN; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CRYSTALLOID; CYTOKINE RELEASE; FEMALE; HEART ATRIUM; HEART CATHETERIZATION; HEART INDEX; HEART PROTECTION; HEMODYNAMIC MONITORING; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPOTENSION; INCIDENCE; INFUSION; INTRAOPERATIVE PERIOD; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SYSTEMIC VASCULAR RESISTANCE; VASCULAR DISEASE; VEIN BLOOD FLOW;

AGED; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRAINAGE; FEMALE; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; POTASSIUM COMPOUNDS; PROSPECTIVE STUDIES;

EID: 33644515296     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Taylor KM. SIRS: the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1607-8.
2. Cremer J, Martin M, Redl H. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61: 1714-20.
3. Royston D. The inflammatory response and extracorporeal circulation. J Cardiothorac Vasc Anesth 1997;11:341-54.
4. Beyersdorf F, Krause E, Sarai K. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg 1997;38:20-9.
5. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 1987;93:127-39.
6. Gallandat-Huet RCG, Karliczek GF, Homan van der Heide JN. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg 1988;36:151-6.
7. Menasché P, Fleury JP, Veyssié L. Limitation of vasodilatation associated with warm heart operation by a "mini-cardioplegia" delivery technique. Ann Thorac Surg 1993;56:1148-53.
8. Bretschneider HJ. Überlebens- und Wiederbelebungszeit des Herzens bei Normo- und Hypothermic. Verh Dtsch Ges Kreislaufforsch. 1964;30:11-34.
9. Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG. Myocardial resistance and tolerance to ischemia. J Cardiovasc Surg. 1975;16:241-60.
10. Taylor KM, Bain WH, Jones JV, Walker MS. The effect of hemodilution on plasma levels of cortisol and free cortisol. J Thorac Cardiovasc Surg 1976;72:57-61.
11. Matthews JNS, Altmann DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J. 1990;300: 230-5.
12. Godfrey KAM. Comparing the means of several groups. N Engl J Med 1985;313:1450-6.
13. Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology and clinical importance. J Card Surg 2000;15:347-53.
14. Kristof AS, Magder S. Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med 1999;27:1121-7.
15. Louagie Y, Gonzalez M, Collard E, Gruslin A, Buche M, Schoevaerdts JC et al. Assesment of two venous drainage techniques in coronary artery bypass graft surgery. Thorac Cardiovasc Surg 1989;37:169-73.
16. Tassani P, Richter JA, Eising GP. Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1999;13:285-91.
17. Babka RM, Petress J, Briggs R, Helsal R, Mack J. Conventional hemofiltration during routine coronary bypass surgery. Perfusion 1997;12:187-92.
18. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996;111:469-77.
19. Strüber M, Cremer JT, Gohrbandt B, Hagl C, Janowski M, Völker B et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 1999;68:1330-5.
20. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 1994;81:1181-9.